 | • レポートコード：MRC2-11QY00362 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はコクシジオイデス症治療薬のグローバル市場について調査・分析したレポートです。種類別（VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他）市場規模、用途別（クリニック、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別コクシジオイデス症治療薬の競争状況、市場シェア ・世界のコクシジオイデス症治療薬市場：種類別市場規模 2015年-2020年（VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他） ・世界のコクシジオイデス症治療薬市場：種類別市場規模予測 2021年-2026年（VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他） ・世界のコクシジオイデス症治療薬市場：用途別市場規模 2015年-2020年（クリニック、病院、その他） ・世界のコクシジオイデス症治療薬市場：用途別市場規模予測 2021年-2026年（クリニック、病院、その他） ・北米のコクシジオイデス症治療薬市場分析：米国、カナダ ・ヨーロッパのコクシジオイデス症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのコクシジオイデス症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のコクシジオイデス症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのコクシジオイデス症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Amplyx Pharmaceuticals Inc、Valley Fever Solutions Inc、Viamet Pharmaceuticals Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Coccidioidomycosis Drug Market
The global Coccidioidomycosis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Coccidioidomycosis Drug Scope and Market Size
Coccidioidomycosis Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Coccidioidomycosis Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Coccidioidomycosis Drug market is segmented into
VT-1161
APX-001
VT-1598
nikkomycin Z
Others
Segment by Application, the Coccidioidomycosis Drug market is segmented into
Clinic
Hospital
Others
Regional and Country-level Analysis
The Coccidioidomycosis Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Coccidioidomycosis Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Coccidioidomycosis Drug Market Share Analysis
Coccidioidomycosis Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Coccidioidomycosis Drug business, the date to enter into the Coccidioidomycosis Drug market, Coccidioidomycosis Drug product introduction, recent developments, etc.
The major vendors covered:
Amplyx Pharmaceuticals Inc
Valley Fever Solutions Inc
Viamet Pharmaceuticals Inc
…
1 Study Coverage
1.1 Coccidioidomycosis Drug Product Introduction
1.2 Market Segments
1.3 Key Coccidioidomycosis Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Coccidioidomycosis Drug Market Size Growth Rate by Type
1.4.2 VT-1161
1.4.3 APX-001
1.4.4 VT-1598
1.4.5 nikkomycin Z
1.4.6 Others
1.5 Market by Application
1.5.1 Global Coccidioidomycosis Drug Market Size Growth Rate by Application
1.5.2 Clinic
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Coccidioidomycosis Drug Market Size, Estimates and Forecasts
2.1.1 Global Coccidioidomycosis Drug Revenue 2015-2026
2.1.2 Global Coccidioidomycosis Drug Sales 2015-2026
2.2 Global Coccidioidomycosis Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Coccidioidomycosis Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Coccidioidomycosis Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Coccidioidomycosis Drug Competitor Landscape by Players
3.1 Coccidioidomycosis Drug Sales by Manufacturers
3.1.1 Coccidioidomycosis Drug Sales by Manufacturers (2015-2020)
3.1.2 Coccidioidomycosis Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Coccidioidomycosis Drug Revenue by Manufacturers
3.2.1 Coccidioidomycosis Drug Revenue by Manufacturers (2015-2020)
3.2.2 Coccidioidomycosis Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Coccidioidomycosis Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Coccidioidomycosis Drug Revenue in 2019
3.2.5 Global Coccidioidomycosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Coccidioidomycosis Drug Price by Manufacturers
3.4 Coccidioidomycosis Drug Manufacturing Base Distribution, Product Types
3.4.1 Coccidioidomycosis Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Coccidioidomycosis Drug Product Type
3.4.3 Date of International Manufacturers Enter into Coccidioidomycosis Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Coccidioidomycosis Drug Market Size by Type (2015-2020)
4.1.1 Global Coccidioidomycosis Drug Sales by Type (2015-2020)
4.1.2 Global Coccidioidomycosis Drug Revenue by Type (2015-2020)
4.1.3 Coccidioidomycosis Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Coccidioidomycosis Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Coccidioidomycosis Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Coccidioidomycosis Drug Revenue Forecast by Type (2021-2026)
4.2.3 Coccidioidomycosis Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Coccidioidomycosis Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Coccidioidomycosis Drug Market Size by Application (2015-2020)
5.1.1 Global Coccidioidomycosis Drug Sales by Application (2015-2020)
5.1.2 Global Coccidioidomycosis Drug Revenue by Application (2015-2020)
5.1.3 Coccidioidomycosis Drug Price by Application (2015-2020)
5.2 Coccidioidomycosis Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Coccidioidomycosis Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Coccidioidomycosis Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Coccidioidomycosis Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Coccidioidomycosis Drug by Country
6.1.1 North America Coccidioidomycosis Drug Sales by Country
6.1.2 North America Coccidioidomycosis Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Coccidioidomycosis Drug Market Facts & Figures by Type
6.3 North America Coccidioidomycosis Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Coccidioidomycosis Drug by Country
7.1.1 Europe Coccidioidomycosis Drug Sales by Country
7.1.2 Europe Coccidioidomycosis Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Coccidioidomycosis Drug Market Facts & Figures by Type
7.3 Europe Coccidioidomycosis Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Coccidioidomycosis Drug by Region
8.1.1 Asia Pacific Coccidioidomycosis Drug Sales by Region
8.1.2 Asia Pacific Coccidioidomycosis Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Coccidioidomycosis Drug Market Facts & Figures by Type
8.3 Asia Pacific Coccidioidomycosis Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Coccidioidomycosis Drug by Country
9.1.1 Latin America Coccidioidomycosis Drug Sales by Country
9.1.2 Latin America Coccidioidomycosis Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Coccidioidomycosis Drug Market Facts & Figures by Type
9.3 Central & South America Coccidioidomycosis Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Coccidioidomycosis Drug by Country
10.1.1 Middle East and Africa Coccidioidomycosis Drug Sales by Country
10.1.2 Middle East and Africa Coccidioidomycosis Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Coccidioidomycosis Drug Market Facts & Figures by Type
10.3 Middle East and Africa Coccidioidomycosis Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Amplyx Pharmaceuticals Inc
11.1.1 Amplyx Pharmaceuticals Inc Corporation Information
11.1.2 Amplyx Pharmaceuticals Inc Description and Business Overview
11.1.3 Amplyx Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amplyx Pharmaceuticals Inc Coccidioidomycosis Drug Products Offered
11.1.5 Amplyx Pharmaceuticals Inc Related Developments
11.2 Valley Fever Solutions Inc
11.2.1 Valley Fever Solutions Inc Corporation Information
11.2.2 Valley Fever Solutions Inc Description and Business Overview
11.2.3 Valley Fever Solutions Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Valley Fever Solutions Inc Coccidioidomycosis Drug Products Offered
11.2.5 Valley Fever Solutions Inc Related Developments
11.3 Viamet Pharmaceuticals Inc
11.3.1 Viamet Pharmaceuticals Inc Corporation Information
11.3.2 Viamet Pharmaceuticals Inc Description and Business Overview
11.3.3 Viamet Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Viamet Pharmaceuticals Inc Coccidioidomycosis Drug Products Offered
11.3.5 Viamet Pharmaceuticals Inc Related Developments
11.1 Amplyx Pharmaceuticals Inc
11.1.1 Amplyx Pharmaceuticals Inc Corporation Information
11.1.2 Amplyx Pharmaceuticals Inc Description and Business Overview
11.1.3 Amplyx Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amplyx Pharmaceuticals Inc Coccidioidomycosis Drug Products Offered
11.1.5 Amplyx Pharmaceuticals Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Coccidioidomycosis Drug Market Estimates and Projections by Region
12.1.1 Global Coccidioidomycosis Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Coccidioidomycosis Drug Revenue Forecast by Regions 2021-2026
12.2 North America Coccidioidomycosis Drug Market Size Forecast (2021-2026)
12.2.1 North America: Coccidioidomycosis Drug Sales Forecast (2021-2026)
12.2.2 North America: Coccidioidomycosis Drug Revenue Forecast (2021-2026)
12.2.3 North America: Coccidioidomycosis Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Coccidioidomycosis Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Coccidioidomycosis Drug Sales Forecast (2021-2026)
12.3.2 Europe: Coccidioidomycosis Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Coccidioidomycosis Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Coccidioidomycosis Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Coccidioidomycosis Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Coccidioidomycosis Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Coccidioidomycosis Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Coccidioidomycosis Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Coccidioidomycosis Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Coccidioidomycosis Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Coccidioidomycosis Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Coccidioidomycosis Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Coccidioidomycosis Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Coccidioidomycosis Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Coccidioidomycosis Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Coccidioidomycosis Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Coccidioidomycosis Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Coccidioidomycosis Drug Market Segments
Table 2. Ranking of Global Top Coccidioidomycosis Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Coccidioidomycosis Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of VT-1161
Table 5. Major Manufacturers of APX-001
Table 6. Major Manufacturers of VT-1598
Table 7. Major Manufacturers of nikkomycin Z
Table 8. Major Manufacturers of Others
Table 9. Global Coccidioidomycosis Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Coccidioidomycosis Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Coccidioidomycosis Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Coccidioidomycosis Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Coccidioidomycosis Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Coccidioidomycosis Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Coccidioidomycosis Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Coccidioidomycosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Coccidioidomycosis Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coccidioidomycosis Drug as of 2019)
Table 18. Coccidioidomycosis Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Coccidioidomycosis Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Coccidioidomycosis Drug Price (2015-2020) (USD/Pcs)
Table 21. Coccidioidomycosis Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Coccidioidomycosis Drug Product Type
Table 23. Date of International Manufacturers Enter into Coccidioidomycosis Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Coccidioidomycosis Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Coccidioidomycosis Drug Sales Share by Type (2015-2020)
Table 27. Global Coccidioidomycosis Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Coccidioidomycosis Drug Revenue Share by Type (2015-2020)
Table 29. Coccidioidomycosis Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Coccidioidomycosis Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Coccidioidomycosis Drug Sales Share by Application (2015-2020)
Table 32. North America Coccidioidomycosis Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Coccidioidomycosis Drug Sales Market Share by Country (2015-2020)
Table 34. North America Coccidioidomycosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Coccidioidomycosis Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Coccidioidomycosis Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Coccidioidomycosis Drug Sales Market Share by Type (2015-2020)
Table 38. North America Coccidioidomycosis Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Coccidioidomycosis Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Coccidioidomycosis Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Coccidioidomycosis Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Coccidioidomycosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Coccidioidomycosis Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Coccidioidomycosis Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Coccidioidomycosis Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Coccidioidomycosis Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Coccidioidomycosis Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Coccidioidomycosis Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Coccidioidomycosis Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Coccidioidomycosis Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Coccidioidomycosis Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Coccidioidomycosis Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Coccidioidomycosis Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Coccidioidomycosis Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Coccidioidomycosis Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Coccidioidomycosis Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Coccidioidomycosis Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Coccidioidomycosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Coccidioidomycosis Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Coccidioidomycosis Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Coccidioidomycosis Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Coccidioidomycosis Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Coccidioidomycosis Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Coccidioidomycosis Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Coccidioidomycosis Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Coccidioidomycosis Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Coccidioidomycosis Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Coccidioidomycosis Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Coccidioidomycosis Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Coccidioidomycosis Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Coccidioidomycosis Drug Sales Market Share by Application (2015-2020)
Table 72. Amplyx Pharmaceuticals Inc Corporation Information
Table 73. Amplyx Pharmaceuticals Inc Description and Major Businesses
Table 74. Amplyx Pharmaceuticals Inc Coccidioidomycosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Amplyx Pharmaceuticals Inc Product
Table 76. Amplyx Pharmaceuticals Inc Recent Development
Table 77. Valley Fever Solutions Inc Corporation Information
Table 78. Valley Fever Solutions Inc Description and Major Businesses
Table 79. Valley Fever Solutions Inc Coccidioidomycosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Valley Fever Solutions Inc Product
Table 81. Valley Fever Solutions Inc Recent Development
Table 82. Viamet Pharmaceuticals Inc Corporation Information
Table 83. Viamet Pharmaceuticals Inc Description and Major Businesses
Table 84. Viamet Pharmaceuticals Inc Coccidioidomycosis Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Viamet Pharmaceuticals Inc Product
Table 86. Viamet Pharmaceuticals Inc Recent Development
Table 87. Global Coccidioidomycosis Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 88. Global Coccidioidomycosis Drug Sales Market Share Forecast by Regions (2021-2026)
Table 89. Global Coccidioidomycosis Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 90. Global Coccidioidomycosis Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 91. North America: Coccidioidomycosis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 92. North America: Coccidioidomycosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 93. Europe: Coccidioidomycosis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 94. Europe: Coccidioidomycosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Asia Pacific: Coccidioidomycosis Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 96. Asia Pacific: Coccidioidomycosis Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 97. Latin America: Coccidioidomycosis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 98. Latin America: Coccidioidomycosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 99. Middle East and Africa: Coccidioidomycosis Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 100. Middle East and Africa: Coccidioidomycosis Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 102. Key Challenges
Table 103. Market Risks
Table 104. Main Points Interviewed from Key Coccidioidomycosis Drug Players
Table 105. Coccidioidomycosis Drug Customers List
Table 106. Coccidioidomycosis Drug Distributors List
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Coccidioidomycosis Drug Product Picture
Figure 2. Global Coccidioidomycosis Drug Sales Market Share by Type in 2020 & 2026
Figure 3. VT-1161 Product Picture
Figure 4. APX-001 Product Picture
Figure 5. VT-1598 Product Picture
Figure 6. nikkomycin Z Product Picture
Figure 7. Others Product Picture
Figure 8. Global Coccidioidomycosis Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Coccidioidomycosis Drug Report Years Considered
Figure 13. Global Coccidioidomycosis Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Coccidioidomycosis Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Coccidioidomycosis Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Coccidioidomycosis Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Coccidioidomycosis Drug Sales Market Share by Region in 2019
Figure 18. Global Coccidioidomycosis Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Coccidioidomycosis Drug Revenue Market Share by Region in 2019
Figure 20. Global Coccidioidomycosis Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Coccidioidomycosis Drug Revenue in 2019
Figure 22. Coccidioidomycosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Coccidioidomycosis Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Coccidioidomycosis Drug Sales Market Share by Type in 2019
Figure 25. Global Coccidioidomycosis Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Coccidioidomycosis Drug Revenue Market Share by Type in 2019
Figure 27. Global Coccidioidomycosis Drug Market Share by Price Range (2015-2020)
Figure 28. Global Coccidioidomycosis Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Coccidioidomycosis Drug Sales Market Share by Application in 2019
Figure 30. Global Coccidioidomycosis Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Coccidioidomycosis Drug Revenue Market Share by Application in 2019
Figure 32. North America Coccidioidomycosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Coccidioidomycosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Coccidioidomycosis Drug Sales Market Share by Country in 2019
Figure 35. North America Coccidioidomycosis Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Coccidioidomycosis Drug Market Share by Type in 2019
Figure 41. North America Coccidioidomycosis Drug Market Share by Application in 2019
Figure 42. Europe Coccidioidomycosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Coccidioidomycosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Coccidioidomycosis Drug Sales Market Share by Country in 2019
Figure 45. Europe Coccidioidomycosis Drug Revenue Market Share by Country in 2019
Figure 46. Germany Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Coccidioidomycosis Drug Market Share by Type in 2019
Figure 57. Europe Coccidioidomycosis Drug Market Share by Application in 2019
Figure 58. Asia Pacific Coccidioidomycosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Coccidioidomycosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Coccidioidomycosis Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Coccidioidomycosis Drug Revenue Market Share by Region in 2019
Figure 62. China Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Coccidioidomycosis Drug Market Share by Type in 2019
Figure 85. Asia Pacific Coccidioidomycosis Drug Market Share by Application in 2019
Figure 86. Latin America Coccidioidomycosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Coccidioidomycosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Coccidioidomycosis Drug Sales Market Share by Country in 2019
Figure 89. Latin America Coccidioidomycosis Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Coccidioidomycosis Drug Market Share by Type in 2019
Figure 97. Latin America Coccidioidomycosis Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Coccidioidomycosis Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Coccidioidomycosis Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Coccidioidomycosis Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Coccidioidomycosis Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Coccidioidomycosis Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Coccidioidomycosis Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Coccidioidomycosis Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Coccidioidomycosis Drug Market Share by Application in 2019
Figure 110. North America Coccidioidomycosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Coccidioidomycosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Coccidioidomycosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Coccidioidomycosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Coccidioidomycosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Coccidioidomycosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Coccidioidomycosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Coccidioidomycosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Coccidioidomycosis Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Coccidioidomycosis Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
小売薬の世界市場（～2026年） A drug is any substance (other than food that provides nutritional support) that, when inhaled, injected, smoked, consumed, absorbed via a patch on the skin, or dissolved under the tongue causes a temporary physiological (and often psychological) change in the body. Increasing industry share of Asia…- 大麻薬の世界市場（～2026年） Drugs with chemicals taken directly from the marijuana plant，or with synthetic versions of chemicals naturally found in marijuana. Market Analysis and Insights: Global Cannabis Drug Market The global Cannabis Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020,…
- 乱用薬物検査サービスの世界市場（～2026年） Drug of Abuse Testing Services is the use of testing services to avoid the negative effects of drug abuse, to reduce the accidents. In addition to rise in number of substance abusers and increase in number of government initiatives to avoid ill effects of substance abuse at workplace & reduce number…
- 薬物スクリーニング検査サービスの世界市場（～2026年） Market Analysis and Insights: Global Drug Screening Laboratory Service Market The global Drug Screening Laboratory Service market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
- 子宮内膜ポリープ治療薬の世界市場（～2026年） Uterine polyps are common gynecological diseases. Broadly speaking, it refers to all tumors attached to the uterine wall by slender pedicle. Mostly benign. Market Analysis and Insights: Global Uterine Polyps Drug Market The global Uterine Polyps Drug market size is projected to reach US$ XX million …